Population pharmacokinetics and dose optimization of ceftazidime in critically ill children
ObjectiveThe aim of this study was to develop a population pharmacokinetic model for ceftazidime in critically ill children in the pediatric intensive care unit (PICU) and optimize an appropriate dosing regimen for this population.MethodsWe performed a prospective pharmacokinetic study on critically...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1470350/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846151822706737152 |
|---|---|
| author | Mengting Li Liuliu Gao Zuo Wang Lingkong Zeng Chen Chen Jun Wang Sichan Li Maochang Liu Yang Wang |
| author_facet | Mengting Li Liuliu Gao Zuo Wang Lingkong Zeng Chen Chen Jun Wang Sichan Li Maochang Liu Yang Wang |
| author_sort | Mengting Li |
| collection | DOAJ |
| description | ObjectiveThe aim of this study was to develop a population pharmacokinetic model for ceftazidime in critically ill children in the pediatric intensive care unit (PICU) and optimize an appropriate dosing regimen for this population.MethodsWe performed a prospective pharmacokinetic study on critically ill children aged 0.03–15 years. A population pharmacokinetic model was developed using the NLME program. Statistical and graphical methods were used to assess the stability and predictive performance of the model. Monte Carlo simulations were conducted to determine the optimal ceftazidime dosing regimen to achieve 70% fT > minimum inhibitory concentration (MIC).ResultsThis study included 88 critically ill children and 100 ceftazidime serum concentrations. The pharmacokinetic characteristics of ceftazidime were best described by a one-compartment linear elimination model. The weight and estimated glomerular filtration rate (eGFR) were determinant covariates for the clearance (CL) of ceftazidime. The recommended ceftazidime dosage regimens achieved a probability of target attainment (PTA) >90% for critically ill children at MIC values of 2, 4, and 8 mg/L. For bacterial infection at an MIC of 16 mg/L, it is difficult to achieve effective pharmacodynamic (PD) targets in vivo with the commonly used dose of ceftazidime.ConclusionThe population pharmacokinetic model of ceftazidime was established in critically ill children. Based on this model, we recommend evidence-based, individualized dosing regimens for subgroups with different weights and renal functions. The current daily dosage for children adequately meets the treatment requirements for MICs of 2, 4, and 8 mg/L, while for bacterial infection at an MIC of 16 mg/L, an elevated dosage regimen may be required.Clinical Trial Registrationhttps://www.medicalresearch.org.cn/login, Identifier MR-42-22-000220. |
| format | Article |
| id | doaj-art-42ca941e56004d71bcbaa51059b40c20 |
| institution | Kabale University |
| issn | 1663-9812 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj-art-42ca941e56004d71bcbaa51059b40c202024-11-27T04:34:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122024-11-011510.3389/fphar.2024.14703501470350Population pharmacokinetics and dose optimization of ceftazidime in critically ill childrenMengting Li0Liuliu Gao1Zuo Wang2Lingkong Zeng3Chen Chen4Jun Wang5Sichan Li6Maochang Liu7Yang Wang8Department of Clinical Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Clinical Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Neonatology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Neonatology, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Clinical Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Clinical Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Clinical Pharmacy, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDrug Clinical Trial Institution, Wuhan Children’s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaObjectiveThe aim of this study was to develop a population pharmacokinetic model for ceftazidime in critically ill children in the pediatric intensive care unit (PICU) and optimize an appropriate dosing regimen for this population.MethodsWe performed a prospective pharmacokinetic study on critically ill children aged 0.03–15 years. A population pharmacokinetic model was developed using the NLME program. Statistical and graphical methods were used to assess the stability and predictive performance of the model. Monte Carlo simulations were conducted to determine the optimal ceftazidime dosing regimen to achieve 70% fT > minimum inhibitory concentration (MIC).ResultsThis study included 88 critically ill children and 100 ceftazidime serum concentrations. The pharmacokinetic characteristics of ceftazidime were best described by a one-compartment linear elimination model. The weight and estimated glomerular filtration rate (eGFR) were determinant covariates for the clearance (CL) of ceftazidime. The recommended ceftazidime dosage regimens achieved a probability of target attainment (PTA) >90% for critically ill children at MIC values of 2, 4, and 8 mg/L. For bacterial infection at an MIC of 16 mg/L, it is difficult to achieve effective pharmacodynamic (PD) targets in vivo with the commonly used dose of ceftazidime.ConclusionThe population pharmacokinetic model of ceftazidime was established in critically ill children. Based on this model, we recommend evidence-based, individualized dosing regimens for subgroups with different weights and renal functions. The current daily dosage for children adequately meets the treatment requirements for MICs of 2, 4, and 8 mg/L, while for bacterial infection at an MIC of 16 mg/L, an elevated dosage regimen may be required.Clinical Trial Registrationhttps://www.medicalresearch.org.cn/login, Identifier MR-42-22-000220.https://www.frontiersin.org/articles/10.3389/fphar.2024.1470350/fullpediatric intensive care unitchildrenceftazidimepopulation pharmacokineticsdose optimization |
| spellingShingle | Mengting Li Liuliu Gao Zuo Wang Lingkong Zeng Chen Chen Jun Wang Sichan Li Maochang Liu Yang Wang Population pharmacokinetics and dose optimization of ceftazidime in critically ill children Frontiers in Pharmacology pediatric intensive care unit children ceftazidime population pharmacokinetics dose optimization |
| title | Population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| title_full | Population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| title_fullStr | Population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| title_full_unstemmed | Population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| title_short | Population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| title_sort | population pharmacokinetics and dose optimization of ceftazidime in critically ill children |
| topic | pediatric intensive care unit children ceftazidime population pharmacokinetics dose optimization |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2024.1470350/full |
| work_keys_str_mv | AT mengtingli populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT liuliugao populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT zuowang populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT lingkongzeng populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT chenchen populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT junwang populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT sichanli populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT maochangliu populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren AT yangwang populationpharmacokineticsanddoseoptimizationofceftazidimeincriticallyillchildren |